Weight gain in patients starting Dolutegravir-based ART according to baseline CD4 count after 48 weeks of follow up

BACKGROUND: Excessive weight gain is a current concern among People Living with HIV (PLHIV) starting ART. OBJECTIVES: To evaluate the weight gain after 48-weeks of ART in naive patients, according with baseline CD4 count. METHODS: PLHIV starting 3TC + TDF + DTG with at least 48-weeks of follow up in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso-Neto, Érico C., Netto, Eduardo Martins, Brites, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569987/
https://www.ncbi.nlm.nih.gov/pubmed/37788801
http://dx.doi.org/10.1016/j.bjid.2023.102807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569987/
https://www.ncbi.nlm.nih.gov/pubmed/37788801
http://dx.doi.org/10.1016/j.bjid.2023.102807

Ejemplares similares